Literature DB >> 30793832

Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers-Danlos syndrome.

Sherene Shalhub1, Enid Neptune2, Desiree E Sanchez1, Anahita Dua3, Nelson Arellano4, Nazli B McDonnell5, Dianna M Milewicz6.   

Abstract

Vascular Ehlers-Danlos syndrome (vEDS) is a connective tissue disorder due to defective type III collagen production and is associated with arterial rupture, spontaneous intestinal perforation, and gravid uterine rupture. Spontaneous pneumothorax and/or hemothorax (P/HTX) also occurs in vEDS patients. The temporal relation of pulmonary manifestations to arterial and intestinal complications in vEDS has not been well described. This was investigated in a multi-institutional retrospective case series of vEDS patients with confirmatory testing for COL3A1 mutation between 2000 and 2012. Data abstracted included demographics, family histories, presentation, and management of associated complications. Ninety-six cases (39% males, mean age 38.6 ± 15.5 years, range 8-79) had confirmatory testing for vEDS. P/HTX was documented in 17 (17.7%) cases. Most P/HTX preceded the diagnosis of vEDS (81%). Diagnosis of vEDS was made after arterial or intestinal complications at a mean of 7 years (range 0-26) post the initial P/HTX. In conclusion, spontaneous P/HTX is an early manifestation of vEDS frequently preceding an arterial complication or intestinal perforation. Thus, a spontaneous P/HTX in a young patient should trigger a differential diagnosis that includes vEDS. This should lead to an investigation of other vEDS features and subsequent genetic testing if vEDS features are present.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ehlers-Danlos syndrome type IV; spontaneous hemothorax; spontaneous pneumothorax; type III collagen; vascular Ehlers-Danlos syndrome

Mesh:

Substances:

Year:  2019        PMID: 30793832     DOI: 10.1002/ajmg.a.61094

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.

Authors:  Sherene Shalhub; Peter H Byers; Kelli L Hicks; Dawn M Coleman; Frank M Davis; Giovanni De Caridi; K Nicole Weaver; Erin M Miller; Marc L Schermerhorn; Katie Shean; Gustavo Oderich; Mauricio Ribeiro; Cole Nishikawa; Kristofer Charlton-Ouw; Christian-Alexander Behrendt; E Sebastian Debus; Yskert von Kodolitsch; Devin Zarkowsky; Richard J Powell; Melanie Pepin; Dianna M Milewicz; Ellen S Regalado; Peter F Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-07-26       Impact factor: 4.268

2.  A Novel COL3A1 c.2644G>T; p.(Gly882Cys) Variant in a Turkish Family with Vascular Ehlers-Danlos Syndrome.

Authors:  Ömer Aydıner; Veysel S Hançer
Journal:  Mol Syndromol       Date:  2020-02-28

3.  Haploinsufficiency of Col5a1 causes intrinsic lung and respiratory changes in a mouse model of classical Ehlers-Danlos syndrome.

Authors:  Jordan Fett; Milena Dimori; John L Carroll; Roy Morello
Journal:  Physiol Rep       Date:  2022-04

4.  Extraction of pulmonary Trachea by dynamic tubular edge contour algorithm.

Authors:  Qing-Wen Fan; Hong-Liang Pei; Feng-Ming Luo; Xiao-Ou Li; Ke Wang; Wen-Jun Jiang
Journal:  Ann Transl Med       Date:  2020-12

5.  The Mystery of Ehlers-Danlos Syndrome: An Autobiographical Case Report.

Authors:  Brandon E Tapasak; David J Malis
Journal:  Cureus       Date:  2022-01-25

Review 6.  A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.

Authors:  Karan Chohan; Nimish Mittal; Laura McGillis; Laura Lopez-Hernandez; Encarna Camacho; Maxim Rachinsky; Daniel Santa Mina; W Darlene Reid; Clodagh Mai Ryan; Kateri Agnes Champagne; Ani Orchanian-Cheff; Hance Clarke; Dmitry Rozenberg
Journal:  Chron Respir Dis       Date:  2021 Jan-Dec       Impact factor: 2.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.